Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

38.84
Delayed Data
As of Jan 23
 -2.43 / -5.89%
Today’s Change
31.25
Today|||52-Week Range
55.15
+0.36%
Year-to-Date

Today’s Trading

Previous close41.27
Today’s open41.27
Day’s range38.77 - 41.57
Volume1,083,543
Average volume (3 months)1,034,586
Market cap$3.6B
Dividend yield--
Data as of 01/23/2017

Growth & Valuation

Earnings growth (last year)-29.63%
Earnings growth (this year)-59.83%
Earnings growth (next 5 years)-36.43%
Revenue growth (last year)--
P/E ratioNM
Price/Sales241.79
Price/Book8.39

Competitors

 Today’s
change
Today’s
% change
TECHBio-Techne Corp-0.12-0.12%
XONIntrexon Corp-1.22-5.23%
BLUEbluebird bio Inc-0.05-0.08%
ARIAARIAD Pharmaceutical...-0.04-0.17%
Data as of 01/23/2017

Financials

Next reporting dateFebruary 16, 2017
EPS forecast (this quarter)-$0.58
Annual revenue (last year)$19.8M
Annual profit (last year)-$88.9M
Net profit margin-449.84%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Kevin Charles Gorman
President &
Chief Operating Officer
David-Alexandre C. Gros
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs